CAS: 432531-71-0
![(E)-N-[4-[N-(3-Methoxypyrazin-2-yl)sulfaMoyl]phenyl]-3-(5-nitrothiophene-2-yl)acrylaMide](https://static.cymitquimica.com/products/AN/thumb/AG00DF2R.jpg)
(E)-N-[4-[N-(3-Methoxypyrazin-2-yl)sulfaMoyl]phenyl]-3-(5-nitrothiophene-2-yl)acrylaMide
CAS:432531-71-0
Formula:
C18H15N5O6S2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
461.4716
Ref: AN-AG00DF2R
| 5mg | 59.00 € | |
| 10mg | 94.00 € | |
| 25mg | 151.00 € | |
| 50mg | 184.00 € | |
| 100mg | 309.00 € | |
| 250mg | 494.00 € |
Estimated delivery in United States, on Thursday 2 May 2024
(E/Z)-Necrosulfonamide
CAS:432531-71-0
(E/Z)-Necrosulfonamide is a novel inhibitor of MLKL.
Formula:
C18H15N5O6S2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
461.47
Ref: TM-T7129
| 5mg | 54.00 € | |
| 10mg | 77.00 € | |
| 25mg | 116.00 € | |
| 50mg | 191.00 € | |
| 100mg | 286.00 € | |
| 1ml*10 (DMSO) | 73.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
N-(4-(N-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophen-2-yl)acrylamide
CAS:432531-71-0
Purity:
98%
Molecular weight:
461.4700012207031
Ref: 10-F546456
| 1g | To inquire | |
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 14 May 2024
Necrosulfonamide
Controlled ProductCAS:432531-71-0
Applications Necrosulfonamide specifically blocks necrosis downstream of receptor-interacting serine-threonine kinase 3 (RIP3) activation. RIP3 is …
Formula:
C18H15N5O6S2
Color and Shape:
Yellow Solid
Molecular weight:
461.47
Ref: TR-N388600
| 1mg | 227.00 € | |
| 10mg | 468.00 € | |
| 100mg | 1,922.00 € |
Estimated delivery in United States, on Wednesday 12 Jun 2024
MLKL Inhibitor, Necrosulfonamide
CAS:432531-71-0
Necrosulfonamide is a chemical inhibitor of MLKL, a protein that is involved in apoptosis and …
Formula:
C18H15N5O6S2
Purity:
Min. 95%
Molecular weight:
461.47 g/mol
Ref: 3D-HSA53171
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 13 Jun 2024
